Menvielle maintains that "the therapist should focus on helping the child and family cope with intolerance and social prejudice, not on the childs behaviours, interests or choice of playmates". A host of additional terms have been applied to these children, including gender variant, gender non-conforming, and gender-creative. See also
Childhood gender nonconformity
Transgender youth
List of transgender-related topics

References
External links

Gender Dysphoria and Transsexualism Archived 17 June 2019 at the Wayback Machine via Merck Manual
More Children Seek Help for Gender Dysphoria via WebMD.com
Health Effects Of Transitioning In Teen Years Remain Unknown via NPR
When Transgender Kids Transition, Medical Risks are Both Known and Unknown via Frontline PBS
Parents of transgender children are faced with a difficult decision via NYMag.com
The boy who was raised a girl via BBC
Led by the child who simply knew The twin boys were identical in every way but one. via Boston.com
A nonprofit program serving transgender and gender-variant youth and their families. via Camp Aranutiq
As Attention Grows, Transgender Childrens Numbers Are Elusive via The New York Times
First U.S. Study of Transgender Youth Funded by NIH via University of California, San Francisco
Where Transgender Is No Longer a Diagnosis via Scientific American
The dissociative anesthetic ketamine is theoretically useful if intubation and mechanical ventilation is needed in people who are approaching respiratory arrest; however, there is no evidence from clinical trials to support this. For those with severe persistent asthma not controlled by inhaled corticosteroids and LABAs, bronchial thermoplasty may be an option. It involves the delivery of controlled thermal energy to the airway wall during a series of bronchoscopies. While it may increase exacerbation frequency in the first few months it appears to decrease the subsequent rate. Effects beyond one year are unknown. Monoclonal antibody injections such as mepolizumab, dupilumab, or omalizumab may be useful in those with poorly controlled atopic asthma. However, as of 2019 these medications are expensive and their use is therefore reserved for those with severe symptoms to achieve cost-effectiveness. Monoclonal antibodies targeting interleukin-5 (IL-5) or its receptor (IL-5R), including mepolizumab, reslizumab or benralizumab, in addition to standard care in severe asthma is effective in reducing the rate of asthma exacerbations. There is limited evidence for improved health-related quality of life and lung function. Evidence suggests that sublingual immunotherapy in those with both allergic rhinitis and asthma improve outcomes. It is unclear if non-invasive positive pressure ventilation in children is of use as it has not been sufficiently studied. Alternative medicine
Many people with asthma, like those with other chronic disorders, use alternative treatments; surveys show that roughly 50% use some form of unconventional therapy. There is little data to support the effectiveness of most of these therapies.